RetMap
1 known investors
RetMap develops electroretinography (ERG) devices for detecting retinal and eye diseases in human and veterinary medicine. The company's FDA-cleared RM Electrode is a disposable contact lens electrode designed to improve diagnostic sensitivity and enable earlier disease detection.